Xcyst® 500 mg
- Product
Xcyst 500 mg, enteric-coated tablets
- Authorisation
NL-RVG 04480
- Active ingredient
Methenamine amygdalate 500 mg
- Indication
Uncomplicated urinary tract infections
- Storage condition
Between 15 – 25 °C
Xcyst tablets are used for the treatment of uncomplicated urinary tract infections (cystitis) if conventional treatment with antibiotics is not effective or contraindicated.
The tablets are gastric acid resistant; tablets should be swallowed whole. The tablets should never be crushed (not even for enteral tube feeding).
Legal status
Xcyst is a licensed medicine in the Netherlands.
When this medicine is supplied outside the Netherlands, it is considered to be an unlicensed medicine in the country of the recipient.
Availability for (Hospital) Pharmacies
In the Netherlands, Xcyst is distributed to (hospital)pharmacies by the pharmaceutical wholesalers.
(Hospital) Pharmacies outside the Netherland that would like to know more about the availability of this product are welcome to contact us via our contact form.
Downloads
